A Quantum Computing Pipeline for Real World Drug Discovery: From Algorithm to Quantum Hardware

Weitang Li,Zhi Yin,Xiaoran Li,Dongqiang Ma,Shuang Yi,Zhenxing Zhang,Chenji Zou,Kunliang Bu,Maochun Dai,Jie Yue,Yuzong Chen,Xiaojin Zhang,Shengyu Zhang

DOI: https://doi.org/10.1101/2024.01.08.574600

2024-02-17

Abstract:Quantum computing, with its superior computational capabilities compared to classical approaches, holds the potential to revolutionize numerous scientific domains, including pharmaceuticals. However, the application of quantum computing for drug discovery has primarily been limited to proof-of-concept studies, which often fail to capture the intricacies of real-world drug development challenges. In this study, we diverge from conventional investigations by developing an advanced quantum computing pipeline tailored to address genuine drug design problems. Our approach underscores the pragmatic application of quantum computation and propels it towards practical industrial adoption. We specifically construct our versatile quantum computing pipeline to address two critical tasks in drug discovery: the precise determination of Gibbs free energy profiles for prodrug activation involving covalent bond cleavage, and the accurate simulation of covalent bond interactions. This work serves as a pioneering effort in benchmarking quantum computing against veritable scenarios encountered in drug design, especially the covalent bonding issue present in both of the case studies, thereby transitioning from theoretical models to tangible applications. Our results demonstrate the potential of a quantum computing pipeline for integration into real world drug design workflows.

Bioinformatics

What problem does this paper attempt to address?

The paper aims to address the challenges of applying quantum computing to practical drug discovery. Currently, the application of quantum computing in drug design is primarily limited to concept validation and fails to fully consider the complexity of real-world drug development. The research team has developed an advanced quantum computing pipeline specifically designed for practical drug design problems, particularly in accurately calculating the Gibbs free energy profile during the pre-activation process involving covalent bond breaking, as well as accurately simulating covalent bond interactions. Through this approach, they hope to promote the practical application of quantum computing in the industry and integrate it into the actual drug design workflow. The paper demonstrates the potential of quantum computing in simulating covalent bond breaking and covalent inhibition of drug targets such as the KRAS protein through two case studies, providing new tools and methods for drug discovery.